Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04726527 · ClinicalTrials.gov registry record
Clinical Evaluation of Florbetapir in Primary Progressive Aphasia
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 48
- Enrollment target
NCT04726527 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 48 participants.
The verdict
NCT04726527 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The purpose of this research is to better understand how dementia affects activity in different parts of the brain.
Interventions
- DEVICE Positron Emission Tomography
- DRUG Florbetapir F 18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-03-15 |
| Est. Completion | 2017-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04726527
The ClinicalTrials.gov registry entry for NCT04726527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Positron Emission Tomography is the first listed.
NCT04726527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04726527 about?
NCT04726527 is a clinical study titled "Clinical Evaluation of Florbetapir in Primary Progressive Aphasia". The purpose of this research is to better understand how dementia affects activity in different parts of the brain.
What is the current status of trial NCT04726527?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2012-03-15. Estimated completion is 2017-02-28.
What interventions are being tested in trial NCT04726527?
The interventions under investigation include: Positron Emission Tomography (DEVICE), Florbetapir F 18 (DRUG).
Who is sponsoring clinical trial NCT04726527?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.